The nurse is caring for a patient with migraine headaches. Which assessment best indicates that suma agonist, is exerting the desired therapeutic effect?
The patient experiences decreased frequency of migraine headaches.
The patient does not experience any more migraine headaches.
The patient reports the termination of the migraine headache after the drug is administered.
The patient experiences increased nausea associated with the migraine headache.
The Correct Answer is C
Choice A rationale: While a decreased frequency of migraine headaches is a positive outcome, it does not directly indicate the immediate therapeutic effect of a sumatriptan (a serotonin receptor agonist). It may suggest a preventive effect over time.
Choice B rationale: Complete absence of migraine headaches is a positive outcome, but it is not always achievable. Immediate cessation of all headaches might not be realistic with every dose.
Choice C rationale: This is correct. Sumatriptan, a serotonin receptor agonist, is designed to terminate or relieve an ongoing migraine headache when administered during an attack. The patient reporting the termination of the migraine headache after drug administration suggests the desired therapeutic effect.
Choice D rationale: Increased nausea is not a desired therapeutic effect of sumatriptan. Sumatriptan is used to relieve the symptoms of migraines, including nausea, not exacerbate them.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A rationale: Epinephrine does increase the speed of conduction, but it does not significantly contribute to gluconeogenesis.
Choice B rationale: Epinephrine is used in cardiac arrest to increase heart rate, contractility, and conduction. In asthma, it causes bronchodilation.
Choice C rationale: While epinephrine can cause some vasodilation, it is not a primary indication for its use in cardiac arrest or status asthmaticus.
Choice D rationale: Epinephrine causes bronchodilation, not bronchoconstriction.
Correct Answer is A
Explanation
Choice A rationale: Norepinephrine is a neurotransmitter that is active in both the peripheral and central nervous systems.
Choice B rationale: Serotonin is primarily active in the central nervous system.
Choice C rationale: Substance P is a neurotransmitter that functions more in the peripheral nervous system.
Choice D rationale: Dynorphins primarily function in the central nervous system.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.